Cathepsin B Activity Assay (F)
Cathepsin B, a lysosomal cysteine protease, plays a crucial role in apoptosis, the programmed cell death essential for maintaining cellular homeostasis and eliminating damaged or unnecessary cells. Located within lysosomes, cathepsin B participates in the intricate molecular cascade that orchestrates apoptosis. During apoptosis, various signals activate the intrinsic (mitochondrial) pathway, triggering the release of pro-apoptotic factors. Cathepsin B contributes to this process by cleaving Bid, a pro-apoptotic Bcl-2 family member, into its truncated form, tBid. TBid then translocates to the mitochondria, leading to the release of cytochrome c and subsequent activation of caspases, key executioners of apoptosis. Additionally, cathepsin B has been implicated in lysosomal membrane permeabilization (LMP), a phenomenon associated with apoptosis. LMP facilitates the release of cathepsin B into the cytoplasm, amplifying its pro-apoptotic effects. Once in the cytoplasm, cathepsin B can directly activate caspases or cleave anti-apoptotic proteins, promoting the irreversible commitment to cell death. The dysregulation of cathepsin B has been linked to various pathological conditions, including neurodegenerative diseases and cancer. Consequently, understanding the intricate interplay of cathepsin B in apoptosis provides valuable insight into
potential therapeutic strategies targeting these conditions.
This Cathepsin B Activity Assay (F) is manufactured in USA by Eagle Biosciences.
| Size | |
| Sensitivity | N/A |
| Sample Type | Cell Lysate, Tissue Extracts |
| Storage | -20°C |






